Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.8.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2017
Dec. 31, 2016
Current assets:    
Cash and cash equivalents $ 128,273 $ 21,398
Accounts receivable 583 0
Accounts receivable due from related parties 1,377 1,333
Prepaid assets and other 3,458 2,012
Total current assets 133,691 24,743
Property, plant and equipment, net 115,856 10,993
Deferred engineering costs 18,000 0
Other non-current assets 9,276 3,342
Total assets 276,823 39,078
Current liabilities:    
Accounts payable and accrued liabilities 50,563 24,403
Accounts payable due to related parties 0 323
Other current liabilities 1,735 0
Total current liabilities 52,298 24,726
Asset retirement obligation 638 0
Total liabilities 52,936 24,726
Embedded derivative 0 8,753
Commitments and contingencies (Note 7)
Stockholders’ equity:    
Series A convertible preferred stock: par value $0.001 per share; zero and 5.5 million shares authorized and issued, respectively 0 5
Common stock: par value $0.01 and $0.001 per share, respectively; 400 million shares and 200 million shares authorized, respectively; 222.7 million shares and 109.6 million shares issued, respectively 2,043 101
Additional paid-in capital 549,958 102,148
Accumulated deficit (328,114) (96,655)
Total stockholders’ equity 223,887 5,599
Total liabilities and stockholders’ equity $ 276,823 $ 39,078